News for Nyrada Inc. (NYR.AX)

Published at

May 2, 2025 4:07 AM

by themarketherald.com.au

neutral

neutral

Nyrada pushes through to third cohort in Phase 1 trial for NYR-BI03

Nyrada Inc has been given the go-ahead to a third cohort in its Phase 1 clinical trial into its drug for neuroprotection and cardioprotection

NYR.AX

Read more →
Published at

Apr 7, 2025 8:59 AM

by themarketherald.com.au

mixed

mixed

ASX Market Close: Investors wipe $97B in biggest rout since COVID | April 7, 2025

The ASX200 closed down 4.2% at 7,343 points in a $97B wipeout…

LYC.AX TLX.AX NYR.AX

Read more →
Published at

Apr 7, 2025 2:24 AM

by themarketherald.com.au

neutral

neutral

Study finds Nyrada’s lead drug can prevent secondary brain injury

Nyrada Inc has reported strong results from a collaborative study it has been engaged in regarding its lead candidate NYR-BI03

NYR.AX

Read more →
Published at

Mar 31, 2025 2:30 AM

by themarketherald.com.au

neutral

neutral

Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drug

Nyrada Inc has dosed the first cohort of patients in its Phase I first-in-human trial to assess the safety and tolerability of NYR-BI03

NYR.AX

Read more →
Published at

Oct 7, 2024 1:16 AM

by themarketherald.com.au

neutral

neutral

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Nyrada Inc has completed an in-vivo micronucleus on the effects of its NYR-BI03 drug on rats, suggesting it causes no genetic damage

NYR.AX

Read more →
Published at

Oct 7, 2024 12:01 AM

by themarketherald.com.au

positive

positive

ASX Market Open: Aussie market to move higher following Wall Street optimism on jobs report | October 7, 2024

The ASX200 is expected to open 0.38% higher this morning, after a strong jobs report produced optimism on Wall Street on Friday

NYR.AX MM8.AX

Read more →
Published at

Oct 2, 2024 1:26 AM

by smallcaps.com.au

neutral

neutral

Nyrada’s NYR-BI03 shows significant cardioprotective efficacy in preclinical study

A preclinical rat study using Nyrada’s (ASX: NYR) lead drug candidate NYR-BI03 has demonstrated up to 86% efficacy in limiting cardiovascular damage

NYR.AX

Read more →
Published at

Aug 1, 2023 9:12 AM

by themarketherald.com.au

mixed

mixed

TMH Market Close: RBA leaves interest rates unchanged at 4.1pc

The ASX 200 spiked more than 30 points today as the RBA left interest rates unchanged at 4.1 per cent.

WOW.AX SCG.AX RDN.AX MTS.AX GMG.AX COL.AX BBN.AX STA.AX NYR.AX

Read more →
Published at

Jun 26, 2023 8:36 AM

by themarketherald.com.au

mixed

mixed

TMH Market Close: ASX200 closes lower, dragged by utilities sector

The ASX 200closed the day trading lower, dragged by the utilities and financial sectors.The Asian markets also saw losses.

WES.AX API.AX NYR.AX

Read more →
Published at

Apr 30, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

PSQ.AX PGC.AX OSX.AX OPT.AX OPT NOXOF NOX.AX IUGNF IMU.AX GSS.AX CYP.AX CKDXF BPH.AX ATX.AX 4DX.AX ZNO.AX SCU.AX RSH.AX PXSLY PXS.AX PAB.AX OCC.AX NC6.AX KZA.AX KMLXF IHL.AX IDT.AX FDMDF DVL.AX CMP.AX BITRF BIT.AX ARUXF AMT.AX ACR.AX 1AD.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX RNO.AX RHY.AX RHT.AX RGS.AX RAC.AX PYC.AX PNV.AX PCK.AX PBP.AX OVN.AX OSL.AX ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX ICR.AX HCT.AX GTG.AX GLH.AX EYE.AX DXB.AX CSL.AX CPH.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX AT1.AX ARX.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX

Read more →
Published at

Apr 11, 2023 4:42 AM

by stockhead.com.au

positive

positive

ASX Health Stocks: MVP flies high after disclosing US ‘green whistle’ strategy, Imricor signs with prestigious Swiss hospital

Long-awaited US approval for MVP's Penthrox 'green whistle' closer; Imricor establishes first iCMR lab at the University Hospital Lausanne.

NYR.AX MVP.AX IMR.AX

Read more →
Published at

Mar 5, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger

Colossal Biosciences’ plans to bring the Tasmanian tiger and woolly mammoth back to life, but now it’s also betting on the iconic dodo.

TD1.AX RGS.AX RAC.AX FFC.AX EZL.AX PYC.AX PAB.AX OPT.AX OPT MX1.AX CMP.AX CKDXF AMT.AX VTG.AX VLS.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX PXSLY PXS.AX PSQ.AX PNV.AX PGC.AX PBP.AX ONE.AX OCC.AX NYR.AX NC6.AX MVF.AX MEM.AX MEB.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMM.AX HCT.AX GTG.AX GSS.AX EYE.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX ATX.AX ARUXF AMDHF ADR.AX ACR.AX

Read more →
Published at

Feb 16, 2023 7:30 PM

by stockhead.com.au

neutral

neutral

MoneyTalks: Canary Capital’s Paul Hart reckons these are the biotech stocks to pop in the basket

MoneyTalks is Stockhead’s regular recap of the ASX stocks, sectors and trends that fund managers and analysts are looking at right now.

NYR.AX

Read more →
Published at

Feb 14, 2023 3:21 AM

by stockhead.com.au

mixed

mixed

ASX Small Cap Lunch Wrap: Who’s making Valentine’s more expensive today?

The ASX 200 is trading up 0.35% at lunch today, with nine out of 11 sectors in the green.

SHO.AX OLL.AX BCK.AX ADR.AX A3D.AX ZEU.AX TPW.AX RKN.AX RCW.AX NYR.AX NVU.AX MSRDA.AX MOB.AX MCM.AX MAT.AX KNM.AX KNEOF FIJ.AX FAU.AX CAI.AX AEI.AX WEC.AX VPR.AX TTB.AX T3D.AX SKY.AX HSC.AX CLE.AX BYOGF AHQDB.AX AHQ.AX ADXRF

Read more →
Published at

Feb 1, 2023 5:46 PM

by stockhead.com.au

mixed

mixed

Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food citing safety reasons, but the CBD index keeps going up.

PYC.AX PSQ.AX PGC.AX MSB.AX KZA.AX EYE.AX DVL.AX CAN.AX BXN.AX BNOEF BNO.AX ADO.AX SOMNF SOM.AX RSH.AX RHT.AX RGS.AX OSX.AX OSL.AX ONE.AX OIL.AX NXSCF NXS.AX MEB.AX MDC.AX MDBIF KMLXF IVX.AX IUGNF IMU.AX IDT.AX GLH.AX CYP.AX CMP.AX CAJ.AX AT1.AX ADR.AX 1ST.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SCU.AX RNO.AX RHY.AX RAC.AX PXSLY PXS.AX PNV.AX PCK.AX PBP.AX PAB.AX OVN.AX OPT.AX OPT OCC.AX NYR.AX NOXOF NOX.AX NC6.AX MXC.AX MX1.AX MVF.AX MEM.AX MDR.AX LBT.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GTG.AX GSS.AX FDMDF DXB.AX CPH.AX CKDXF CGS.AX CALZF BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX AMDHF ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Jan 19, 2023 5:50 PM

by stockhead.com.au

mixed

mixed

Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI Inc says it is on a mission to halve the world's blindness with its smartphone-based device.

ZNO.AX ZLD.AX RAP.AX PSQ.AX PIQ.AX PBP.AX PAA.AX MXC.AX IPDQF IPD.AX IDT.AX GLH.AX CGS.AX BXN.AX 1AD.AX SOMNF SOM.AX SHL.AX RSH.AX RGS.AX PGC.AX PCK.AX OVN.AX OSX.AX OSL.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDC.AX LBT.AX KZIA KZA.AX KMLXF IVX.AX IMMP IMM.AX IHL.AX GSS.AX FDMDF DVL.AX CYP.AX CPH.AX CAN.AX BWXXF BWX.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX AT1.AX ARX.AX AKU.TO AKU ADR.AX 4DX.AX 1ST.AX VTG.AX VLS.AX UBI.AX SCU.AX RNO.AX RHY.AX RHT.AX RAC.AX PYC.AX PXSLY PXS.AX PNV.AX PAB.AX OPT.AX OPT ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MVF.AX MEM.AX MEB.AX MDR.AX MDBIF IUGNF IMU.AX IMRNW IMRN IMC.AX ICR.AX HCT.AX EYE.AX DXB.AX CMP.AX CKDXF CALZF CAJ.AX ATX.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX

Read more →
Published at

Jan 4, 2023 6:02 PM

by stockhead.com.au

mixed

mixed

Check Up: Moderna posts crazy cancer vaccine results, says melanoma recurrence down by almost half

Moderna’s stock price rose in late December after the company revealed that a vaccine for melanoma showed encouraging results.

TD1.AX RSH.AX PCK.AX MX1.AX KMLXF DVL.AX CAJ.AX BNOEF BNO.AX ARX.AX ADR.AX 1ST.AX ZNO.AX RHY.AX RAC.AX PYC.AX PSQ.AX PGC.AX OVN.AX OSX.AX ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MDC.AX KZA.AX IPDQF IPD.AX IDT.AX GTG.AX CYP.AX CPH.AX CAN.AX BXN.AX BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ZLD.AX VTG.AX VLS.AX UBI.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX RGS.AX PXSLY PXS.AX PNV.AX PBP.AX PAB.AX OSL.AX OPT.AX OPT OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MVF.AX MEM.AX MDR.AX LBT.AX IVX.AX IUGNF IMU.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GSS.AX GLH.AX FDMDF EYE.AX DXB.AX CMP.AX CKDXF CGS.AX CALZF AT1.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Dec 30, 2022 12:31 AM

by stockhead.com.au

mixed

mixed

Top 10 at 10: Which ASX stocks are leading the winners on the last trading day of 2022?

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.

SFG.AX NYR.AX MXC.AX MRR.AX NET.AX AL8.AX

Read more →
Published at

Dec 14, 2022 3:35 AM

by stockhead.com.au

mixed

mixed

ASX Small Caps Lunch Wrap: Where are you hiding all your cash today?

The ASX has had a positive morning, Genesis has the cash to merge with St Barbara, while the rest of Australia is hoarding theirs.

CHN.AX STBMY STBMF SBM.AX PXXXF PUR.AX PAB.AX NYR.AX LME.AX GRL.AX GMD.AX BAT.AX YOW.AX TD1.AX TAR.AX ROG.AX RAN.AX MZZ.AX MTH.AX MOB.AX KFE.AX ICR.AX FHS.AX CLT.AX CAV.AX AQX.AX ANL.AX AMD.AX ADV.AX

Read more →
Published at

Nov 30, 2022 8:10 PM

by stockhead.com.au

mixed

mixed

Check Up: The world's most expensive drug costs $3.5 MILLION a shot

The US FDA has just approved the world’s most expensive drug. CSL Behring’s hemophilia B gene therapy costs US$3.5m a dose.

PAB.AX OCC.AX NC6.AX MDR.AX IMM.AX GTG.AX GSS.AX EYE.AX CSLN.MX CSLLY CSL.AX CMXHF BPH.AX SHL.AX RAC.AX PSQ.AX ONE.AX NYR.AX NXSCF NXS.AX MXC.AX KZA.AX FDMDF DXB.AX DVL.AX CYP.AX CPH.AX CGS.AX AT1.AX ARX.AX ARUXF AMDHF ALC.AX ACR.AX 4DX.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX SCU.AX RSH.AX RNO.AX RHY.AX RHT.AX RGS.AX PYC.AX PXSLY PXS.AX PNV.AX PGC.AX PCK.AX PBP.AX OVN.AX OSX.AX OSL.AX OPT.AX OPT OIL.AX NOXOF NOX.AX MX1.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF LBT.AX KMLXF IVX.AX IUGNF IPDQF IPD.AX IMU.AX IMRNW IMRN IMC.AX IHL.AX IDT.AX ICR.AX HCT.AX GLH.AX CMP.AX CKDXF CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX AMT.AX ADR.AX ADO.AX 1ST.AX 1AD.AX

Read more →